Реєстр перкутанних коронарних втручань: зміни за останні роки (2010–2022)

Sokolov Maksym, М Ю Соколов, І В Данильчук, Д. І. Беш, А. І. Кланца, В. О. Колесник, Олег Рафалюк, В. М. Сало, С. В. Сало, Л.В. Сорохтей, С.М. Фуркало
{"title":"Реєстр перкутанних коронарних втручань: зміни за останні роки (2010–2022)","authors":"Sokolov Maksym, М Ю Соколов, І В Данильчук, Д. І. Беш, А. І. Кланца, В. О. Колесник, Олег Рафалюк, В. М. Сало, С. В. Сало, Л.В. Сорохтей, С.М. Фуркало","doi":"10.31928/2664-4479-2024.1.733","DOIUrl":null,"url":null,"abstract":"In 2022, the number of coronary angiograms in Ukrainian clinics was 51 084, which is 27.6 % more than in 2019, the number of stented patients is 27 513 for all forms of coronary artery disease (scheduled and urgent patients), which is 19.7 % more than in 2019 year and 16 847 stenting were performed in STEMI patients in the first day from the onset of symptoms, which is 12.9 % more than in 2019.During the period of the Register operation, the fact of creation of 66 reperfusion centers was recorded, which are the main part of Regional Reperfusion Networks (RRN) and strive to function in accordance with national unified protocols for the treatment of STEMI, NSTEMI and stable coronary syndromes.Today, the distribution of patients by time from the onset of symptoms to mechanical reperfusion in Ukraine is distributed as follows: in the first 12 hours from the onset of STEMI symptoms, 85 % are present (15 % are «late» patients who are hospitalized at 12–24 hours from the onset of symptoms or later, often requiring urgent coronary angiography and possibly primary stenting). Patients arriving in the «ideal» period for reperfusion (in the first 2 hours) is about 15 %, the largest group of STEMI patients who arrived at the clinic in the first 2–4 hours from the onset of symptoms is 30 %, and the number of patients with AMI in the period of 4–6 hours from the onset of symptoms, the average is 25 %, and the 6–12-hour group completes the analysis by 15 %, respectively.The number of procedures in STEMI patients increased annually, which led to a decrease in hospital mortality in reperfusion centers (55–60 % of patients in catheterization laboratories in Ukraine are STEMI patients) to an average of 4.7 %, and in the general group of AMI in Ukraine to 12.3 %. Unfortunately, 40–45 % of patients are currently hospitalized in clinics without the possibility of primary stenting.A ten-year observation of the dynamics of primary stenting revealed changes, which we called the «reperfusion paradox», which occurred in 2015–2016, which fully confirmed the correct vector of technology development and determined the trend of its development. This phenomenon is the beginning of a natural decrease in the number of fibrinolytic procedures from 27 % (2010 year) to 4.6 % (2021 year), respectively, and an increase in the number of primary procedures in STEMI patients from 4.0 % (2010 year) to 56.4 % (2022 year), which is quite natural and confirms the processes of active development and systemic transformations in interventional cardiology in Ukraine and around the world.As a result, it was found that we have increased 17 times the number of primary percutaneous interventions per million population over the last decade, while European countries have increased the number of similar procedures by only 14 %. This fact indicates the correct direction of development and the speed of movement in this direction.","PeriodicalId":23419,"journal":{"name":"Ukrainian Journal of Cardiology","volume":"56 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ukrainian Journal of Cardiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31928/2664-4479-2024.1.733","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

In 2022, the number of coronary angiograms in Ukrainian clinics was 51 084, which is 27.6 % more than in 2019, the number of stented patients is 27 513 for all forms of coronary artery disease (scheduled and urgent patients), which is 19.7 % more than in 2019 year and 16 847 stenting were performed in STEMI patients in the first day from the onset of symptoms, which is 12.9 % more than in 2019.During the period of the Register operation, the fact of creation of 66 reperfusion centers was recorded, which are the main part of Regional Reperfusion Networks (RRN) and strive to function in accordance with national unified protocols for the treatment of STEMI, NSTEMI and stable coronary syndromes.Today, the distribution of patients by time from the onset of symptoms to mechanical reperfusion in Ukraine is distributed as follows: in the first 12 hours from the onset of STEMI symptoms, 85 % are present (15 % are «late» patients who are hospitalized at 12–24 hours from the onset of symptoms or later, often requiring urgent coronary angiography and possibly primary stenting). Patients arriving in the «ideal» period for reperfusion (in the first 2 hours) is about 15 %, the largest group of STEMI patients who arrived at the clinic in the first 2–4 hours from the onset of symptoms is 30 %, and the number of patients with AMI in the period of 4–6 hours from the onset of symptoms, the average is 25 %, and the 6–12-hour group completes the analysis by 15 %, respectively.The number of procedures in STEMI patients increased annually, which led to a decrease in hospital mortality in reperfusion centers (55–60 % of patients in catheterization laboratories in Ukraine are STEMI patients) to an average of 4.7 %, and in the general group of AMI in Ukraine to 12.3 %. Unfortunately, 40–45 % of patients are currently hospitalized in clinics without the possibility of primary stenting.A ten-year observation of the dynamics of primary stenting revealed changes, which we called the «reperfusion paradox», which occurred in 2015–2016, which fully confirmed the correct vector of technology development and determined the trend of its development. This phenomenon is the beginning of a natural decrease in the number of fibrinolytic procedures from 27 % (2010 year) to 4.6 % (2021 year), respectively, and an increase in the number of primary procedures in STEMI patients from 4.0 % (2010 year) to 56.4 % (2022 year), which is quite natural and confirms the processes of active development and systemic transformations in interventional cardiology in Ukraine and around the world.As a result, it was found that we have increased 17 times the number of primary percutaneous interventions per million population over the last decade, while European countries have increased the number of similar procedures by only 14 %. This fact indicates the correct direction of development and the speed of movement in this direction.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
经皮冠状动脉介入治疗登记:近年来的变化(2010-2022 年)
2022年,乌克兰诊所的冠状动脉造影数量为51084例,比2019年增加了27.6%,为各种形式的冠状动脉疾病(预定和紧急患者)进行支架植入的患者数量为27513例,比2019年增加了19.7%,为STEMI患者在症状出现后第一天进行支架植入的数量为16847例,比2019年增加了12.9%。在登记册运行期间,共建立了 66 个再灌注中心,这些中心是区域再灌注网络(RRN)的主要组成部分,努力按照国家统一协议治疗 STEMI、NSTEMI 和稳定型冠状动脉综合征。目前,乌克兰患者从出现症状到机械再灌注的时间分布如下:在 STEMI 症状出现后的 12 小时内,85% 的患者出现了 STEMI 症状(15% 是 "晚期 "患者,他们在症状出现后 12-24 小时或更晚的时间住院,通常需要紧急冠状动脉造影术,可能还需要初级支架植入术)。在再灌注 "理想 "时期(最初 2 小时内)到达的患者约占 15%,在症状出现后最初 2-4 小时内到达诊所的 STEMI 患者最多,占 30%,而在症状出现后 4-6 小时内的 AMI 患者人数平均占 25%,6-12 小时组分别占 15%,完成了分析。STEMI 患者的手术数量每年都在增加,这导致再灌注中心的住院死亡率(乌克兰导管室 55-60% 的患者为 STEMI 患者)下降至平均 4.7%,乌克兰 AMI 普通组的住院死亡率下降至 12.3%。不幸的是,目前有40%-45%的患者在诊所住院,无法进行初级支架植入术。对初级支架植入术动态的十年观察发现了一些变化,我们称之为 "再灌注悖论",它发生在2015-2016年,充分证实了技术发展的正确矢量,并决定了其发展趋势。这一现象的开端是,纤溶手术的数量分别从27%(2010年)自然下降到4.6%(2021年),而STEMI患者的初次手术数量从4.0%(2010年)增加到56.结果发现,在过去十年中,我国每百万人口经皮介入治疗的数量增加了 17 倍,而欧洲国家类似手术的数量仅增加了 14%。这一事实表明,我们的发展方向是正确的,发展速度也是很快的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.10
自引率
0.00%
发文量
0
期刊最新文献
Risk factors for adverse outcome among patients with non-high risk pulmonary embolism Статеві та клініко-інструментальні паралелі рівнів ліпопротеїн(а) в пацієнтів з дуже високим серцево-судинним ризиком Вибір блокатора ренін-ангіотензин-альдостеронової системи для лікування серцевої недостатності при гострому міокардиті Характеристика пацієнтів з ішемічною хворобою серця та стабільною стенокардією в Україні, оцінка підходів до їх лікування за даними багатоцентрового дослідження GO-OD Порівняльний аналіз субклінічного тривожно-депресивного синдрому в пацієнтів із гострим інфарктом міокарда з елевацією сегмента ST до та під час активних бойових дій у Харківській області
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1